You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 104 No. 7, July 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL SCIENCES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (25)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Temporary Loss of Foveal Contrast Sensitivity Associated With Panretinal Photocoagulation

Kent E. Higgins, PhD; Sanford M. Meyers, MD; Myles J. Jaffe, OD; Monique S. Roy, MD; Francisco M. de Monasterio, MD

Arch Ophthalmol. 1986;104(7):997-1003.


Abstract



• Snellen visual acuity and spatial contrast sensitivity measurements were used to monitor changes in foveal vision in two patients undergoing argon laser panretinal photocoagulation (PRP) in both eyes for proliferative diabetic retinopathy. Foveal edema developed in one of the four eyes. The remaining three eyes showed no signs of foveal edema, but developed temporary losses in high spatial frequency contrast sensitivity during the closely spaced PRP treatments. Since Snellen visual acuity remained stable at the prelaser level, these results indicate the need for more sensitive measures of visual resolution to monitor foveal integrity in patients undergoing PRP.



Author Affiliations



From the Section on Visual Processing, Clinical Branch, National Eye Institute, National Institutes of Health, Bethesda, Md. Dr Meyers is now with the Department of Ophthalmology, Cleveland Clinic.


Footnotes



Accepted for publication Dec 12, 1985.

Reprint requests to the Clinical Branch 10/ 10C422, National Eye Institute, National Institutes of Health, Bethesda, MD 20892 (Dr Higgins).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy
Cho et al.
Br J Ophthalmol 2010;94:858-863.
ABSTRACT | FULL TEXT  

Observational Study of the Development of Diabetic Macular Edema Following Panretinal (Scatter) Photocoagulation Given in 1 or 4 Sittings
Diabetic Retinopathy Clinical Research Network
Arch Ophthalmol 2009;127:132-140.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy Viewed as a Neurosensory Disorder
Bresnick
Arch Ophthalmol 1986;104:989-990.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.